SCHEMBL4426318

SCHEMBL4426318

O=C(c1ccc(I)cc1)c1cc2c3c(c1)c(-c1cccc(Cl)c1)cc(=O)n3CC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 7/20 0.49
FNTB P49356 7/20 0.49
PGGT1B P53609 1/20 0.48
KMT2A Q03164 4/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPT P10636 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
GSK3B P49841 1/20 0.33
UCHL1 P09936 1/20 0.33
USP30 Q70CQ3 1/20 0.33
BRD4 O60885 1/20 0.32
CREBBP Q92793 1/20 0.32
PDE4B Q07343 1/20 0.32
CA12 O43570 1/20 0.32
CA9 Q16790 1/20 0.32
BTK Q06187 1/20 0.32
PLA2G1B P04054 1/20 0.32
ATG4B Q9Y4P1 1/20 0.32
MEN1 O00255 1/20 0.32
CLK1 P49759 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7208658 0.93 FNTA (0.56) FNTAFNTBPGGT1BKMT2AKDM4E
SCHEMBL4432018 0.91 FNTA (0.51) FNTAFNTBPGGT1BKMT2AKDM4E
SCHEMBL4428705 0.87 FNTA (0.56) FNTAFNTBPGGT1BKMT2AKDM4E
SCHEMBL7203358 0.85 FNTA (0.47) FNTAFNTBPGGT1BKMT2AKDM4E
SCHEMBL4434794 0.81 FNTA (0.47) FNTAFNTBPGGT1BKMT2AKDM4E
SCHEMBL4425458 0.79 FNTA (0.50) FNTAFNTBPGGT1BKMT2AKDM4E
SCHEMBL4426275 0.78 FNTA (0.55) FNTAFNTBPGGT1BKMT2AKDM4E
SCHEMBL4424967 0.77 FNTA (0.46) FNTAFNTBPGGT1BKDM4EGSK3B
SCHEMBL29445867 0.77 FNTA (0.53) FNTAFNTBPGGT1BKMT2AKDM4E
SCHEMBL5657960 0.74 FNTA (0.48) FNTAFNTBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458720-B1 1,8-ANNELATED QUINOLINE DERIVATIVES SUBSTITUTED WITH CARBON-LINKED TRIAZOLES AS FARNESYL TRANSFERASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2009-03-18 EP disclosed
US-7408063-B2 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors JANSSEN PHARMACEUTICA, N.V. (BE) 2008-08-05 US disclosed
US-20050176702-A1 1,8-Annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2005-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176702-A1 1,8-Annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors FNTA, FNTB, ACAT2 FNTA 1/4885FNTB 2/4885PGGT1B 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.